RSS
10 Aug 2021

Protagonist Therapeutics Announces Resolution of Contract Dispute with Zealand Pharma

Author: admintech | Filed under: Press Release

NEWARK, Calif., Aug. 10, 2021 /PRNewswire/ — Protagonist Therapeutics, Inc. (Nasdaq: PTGX) (“Protagonist” or “the Company”) today announced it has resolved its Collaboration Agreement dispute with Zealand Pharma by reducing future development and sales milestone payments and royalties…

This entry was posted on Tuesday, August 10th, 2021 at 7:14 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»